Understanding Clinical Trials From Start To Finish

What Clinical Trials Are and Why They Matter

A clinical trial is a research study that tests whether a new medical treatment—such as a drug, device, or therapy—works and is safe for people. These studies are how medical researchers determine if a potential treatment can help patients with a specific condition. Clinical trials follow strict scientific rules and are conducted by teams of doctors, nurses, researchers, and other healthcare professionals.

Learn About Supplemental Security Income and Social Security →

The process of getting a new drug or treatment from the laboratory to a patient's medicine cabinet takes many years and involves hundreds of clinical trials. According to the U.S. Food and Drug Administration (FDA), it typically takes between 10 to 15 years and costs hundreds of millions of dollars to develop a single new medication. Clinical trials are the bridge between early laboratory research and real-world use. Without them, doctors would have no way to know if a treatment actually works in people or what side effects might occur.

Clinical trials involve real people—called participants or subjects—who volunteer to test these treatments. These participants are not paid to take risks; rather, they participate for various reasons. Some hope the experimental treatment might help their own condition. Others participate to contribute to medical knowledge that could help future patients. Still others may receive compensation for their time and travel expenses, though this is not the same as payment for taking on risk.

Different types of trials exist depending on what is being studied. Drug trials test medications. Device trials test medical equipment like pacemakers or artificial joints. Behavioral trials might test whether a new type of therapy or counseling approach works. Surgical trials compare different surgical techniques. Combination trials might test whether two treatments work better together than separately.

Understanding how clinical trials work helps people make informed decisions about their own healthcare. If you or someone you know has a serious condition, knowing about clinical trials may reveal treatment options that would not otherwise be available. Even if you never participate in a trial, understanding how they work helps you understand why your doctor might recommend certain treatments—because those treatments have been tested in clinical trials and shown to be safe and effective.

Practical Takeaway: Clinical trials are essential research studies that test new medical treatments. They involve volunteer participants and take many years to complete. Learning about trials helps you understand how modern medicine develops new treatments and may reveal options for conditions that lack other solutions.

The Four Phases of Clinical Trial Development

Clinical trials move through different phases, each with its own purpose and number of participants. Understanding these phases shows why trials take so long and why they are structured the way they are.

Learn About Finding Your Home's Current Value →

Phase 1 Trials are the earliest testing stage. These trials typically involve between 20 and 100 volunteers. The main goal is to test safety and dosage—researchers want to find out what dose causes problems and what dose appears safe. Phase 1 trials often involve healthy volunteers rather than people with the disease being treated, because the focus is purely on safety. For example, a Phase 1 trial for a new cancer drug would test different dose levels to see which doses cause bad side effects. These trials usually last several months. If Phase 1 shows that a treatment appears reasonably safe, it can move forward.

Phase 2 Trials expand testing to several hundred participants—typically between 100 and 500 people. Now the participants usually have the condition the treatment is meant to help. Researchers continue to watch for side effects but also begin studying whether the treatment actually works. They might measure whether a new blood pressure medication actually lowers blood pressure, or whether a new cancer drug actually shrinks tumors. Phase 2 trials often last several months to two years. Success in Phase 2 means the treatment shows promise both for safety and effectiveness.

Phase 3 Trials involve larger groups, often between 1,000 and 5,000 participants. These trials compare the new treatment to standard existing treatments or to a placebo (a fake treatment). For example, researchers might give some participants the new drug and other participants the drug currently used for that condition. This comparison shows whether the new treatment is actually better. Phase 3 trials often last one to four years because researchers need to track results over time. These large trials provide the strongest evidence about whether a treatment works.

Phase 4 Trials happen after a treatment has already been approved and is on the market. These studies continue to monitor the treatment's safety and effectiveness in larger populations. Phase 4 trials might discover side effects that only appear in certain groups of people or after long-term use. They might also find new uses for existing drugs. Phase 4 trials can involve tens of thousands of people and continue indefinitely.

The FDA must review data from Phases 1 through 3 before approving a treatment for public use. The entire process from Phase 1 through approval takes an average of 6 to 7 years for most drugs, though some move faster or slower depending on the condition and research.

Practical Takeaway: Clinical trials progress through four phases that gradually increase the number of participants and expand the questions being asked. Phase 1 focuses on safety; Phase 2 examines both safety and whether the treatment works; Phase 3 compares the new treatment to existing treatments using large groups; Phase 4 monitors treatments after they reach the market. Each phase builds on information from the previous one.

Who Participates in Clinical Trials and How People Join

Clinical trial participants come from many different backgrounds. Some are healthy volunteers participating in Phase 1 trials to test safety. Most are people living with the condition being studied—patients with diabetes, heart disease, depression, cancer, or any number of other conditions. Participants range from children to elderly people, though different trials accept different age groups.

Get Your Free Mobile Car Detailing Service Guide →

Each trial establishes specific requirements called inclusion and inclusion criteria that describe who can participate. For example, a trial might only accept people between ages 50 and 75, or people with a specific stage of cancer, or people not taking certain other medications. These requirements exist for scientific reasons—researchers need to study fairly similar groups of people so that results are meaningful. A trial testing a heart medication might exclude pregnant women because the drug's effects on pregnancy are unknown and must be studied separately.

People learn about clinical trials through several routes. Some doctors tell their patients about trials that might help their condition. Others find trials by searching clinical trial databases. The largest public database is ClinicalTrials.gov, operated by the National Institutes of Health. This free website lists over 400,000 trials worldwide. Patients can search by condition, location, and treatment type to find trials accepting participants. Hospital websites and disease-specific organizations—such as the American Cancer Society or American Heart Association—also provide information about trials.

Once someone finds a trial they are interested in, they contact the trial's research team. This typically involves a screening appointment where researchers explain the trial in detail and ask questions to determine whether the person meets the requirements. If the person seems to be a good fit, researchers provide detailed written information and allow time for questions. This is the informed consent process—the person must understand what participating involves before deciding whether to join.

Participation is always voluntary. Participants can withdraw from a trial at any time without penalty or loss of medical care. No one should feel pressured to join a trial. Good clinical trial teams explain both the potential benefits and the potential risks. They answer questions fully and encourage people to discuss the trial with family members or their own doctor before deciding.

Researchers must protect participant privacy. Trial data uses code numbers rather than names, and the research team limits who has access to information. Trials have ethics committees called Institutional Review Boards (IRBs) that review all research to ensure participant safety and rights are protected.

Practical Takeaway: Clinical trial participants are people with and without medical conditions who meet specific study requirements. People can find trials through ClinicalTrials.gov, their doctors, or disease organizations. Participation is voluntary, and people can withdraw at any time. Researchers must protect participant privacy and safety through ethics review boards.

Understanding Risks, Benefits, and the Informed Consent Process

Every clinical trial carries some level of risk. Participants might experience side effects from an experimental treatment. An experimental treatment might not work. In rare cases, serious complications can occur. Being transparent about these risks is essential to ethical research.

Learn About Filing Unemployment in Michigan →

Potential benefits also exist. Some participants receive an experimental treatment that turns out to help their condition better than existing treatments. Others receive excellent medical monitoring that catches health problems early. Still others feel satisfied knowing they have contributed to medical knowledge that might help future patients. However, research shows that most people choose to participate for a